Objective To study the efficacy of treating advanced non-small cell lung cancer (NSCLC) with autologous cytokine-induced killer (CIK) cells combined with chemotherapy combined with biotherapy.

• 摘要目的研究自体细胞因子诱导的杀伤细胞(CIK)细胞联合化疗治疗晚期非小细胞的疗效。